Financial law

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Friday, July 16, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

ESMA publishes its third report on CSDR implementation

Retrieved on: 
Friday, July 16, 2021

16 July 2021

Key Points: 
  • 16 July 2021

    Post Trading

    The European Securities and Markets Authority (ESMA), the EUs securities markets regulator, has today published its CSDR Report on the provision of banking-type ancillary services by central securities depositories (CSDs).

  • The report contains suggestions to enhance the authorisation process for CSDs to provide banking-type ancillary services themselves.
  • More importantly, it also includes several proposals to facilitate the provision of banking-type ancillary services by non-banking CSDs;in particular to enable them to offer settlement services in foreign currencies.
  • ESMAs recommendations will inform the European Commissions ongoing CSDR Targeted Review, which has identified facilitating the provision of banking-type ancillary services as a key policy priority.

Form 8.3 - The Vanguard Group, Inc.: UDG Healthcare plc

Retrieved on: 
Friday, July 16, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Amundi Physical Metals plc: Final Terms

Retrieved on: 
Friday, July 16, 2021

The ETC Securities are designed to provide purchasers with exposure to Gold without having to take physical delivery of the Gold.

Key Points: 
  • The ETC Securities are designed to provide purchasers with exposure to Gold without having to take physical delivery of the Gold.
  • Each ETC Security relates to a specific amount in weight of Gold, specified in the Final Terms, known as the "Metal Entitlement".
  • Payment of any Early Redemption Amount or the Final Redemption Amount is subject at all times to the limited recourse provisions.
  • Any early or final redemption of the ETC Securities of a Series will be settled in cash.

Form 8.3 - The Vanguard Group, Inc.: Aon plc

Retrieved on: 
Friday, July 16, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

Retrieved on: 
Friday, July 16, 2021

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.

Key Points: 
  • Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced.
  • If none, this should be stated.
  • Is a Supplemental Form 8 attached?
  • (Note 9) NO

WELBILT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of WBT and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 15, 2021

On July 14, 2021, Welbilt announced that it had entered into an agreement to be acquired by Ali Group in a transaction valued at approximately $4.8 billion.

Key Points: 
  • On July 14, 2021, Welbilt announced that it had entered into an agreement to be acquired by Ali Group in a transaction valued at approximately $4.8 billion.
  • Pursuant to the merger agreement, Welbilt stockholders will receive $24 in cash for each share of Welbilt common stock owned.
  • Bragar Eagel & Squire is concerned that Welbilts board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders

Retrieved on: 
Thursday, July 15, 2021

The U.K. Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering.

Key Points: 
  • The U.K. Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering.
  • The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the offering.
  • Furthermore, it is noted that, notwithstanding the Target Market Assessment, the underwriters will only procure investors who meet the criteria of professional clients or eligible counterparties.
  • Each distributor is responsible for undertaking its own target market assessment in respect of the securities and determining appropriate distribution channels.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Provention Bio, Washington Prime, Virgin Galactic, and RLX and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, July 15, 2021

On this news, Provention's stock price fell $1.73 per share, or 17.78%, to close at $8.00 per share on April 9, 2021.

Key Points: 
  • On this news, Provention's stock price fell $1.73 per share, or 17.78%, to close at $8.00 per share on April 9, 2021.
  • The Company further advised that, in an event of default, certain counterparties to the senior notes could accelerate the outstanding indebtedness due .
  • For more information on the RLX class action go to: https://bespc.com/cases/RLX
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

KANZHUN LIMITED CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that securities class action lawsuits have been filed against Kanzhun Limited

Retrieved on: 
Wednesday, July 14, 2021

All investors who purchased the ADRs of Kanzhun Limited and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.

Key Points: 
  • All investors who purchased the ADRs of Kanzhun Limited and incurred losses are urged to contact the firm immediately at [email protected] or (800) 575-0735 or (212) 545-4774.
  • You may obtain additional information concerning the action or join the case on our website, www.whafh.com.
  • Please contact Wolf Haldenstein to learn more about your rights as an investor in the ADRs of Kanzhun Limited.
  • Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country.